PMM2 and congenital disorder of glycosylation: Future efforts should be made to better characterize the PMM2 knockdown THP-1 monocytes and possibly to create a genetic model that fully mimics the PMM2 mutations found in patients and use all these immune cell models to investigate several aspects of immunological dysfunctions in CDG patients.